Accessibility Menu
TerrAscend Stock Quote

TerrAscend (OTC: TRSSF)

$0.80
(6.0%)
+0.05
Price as of October 22, 2025, 3:59 p.m. ET

KEY DATA POINTS

Current Price
$0.8
Daily Change
(6.0%) +$0.05
Day's Range
$0.67 - $0.83
Previous Close
$0.8
Open
$0.73
Beta
1.02
Volume
728,772
Average Volume
748,540
Market Cap
232M
Market Cap / Employee
$0.76M
52wk Range
$0.23 - $1.25
Revenue
-
Gross Margin
0.48%
Dividend Yield
N/A
EPS
-$0.4
CAPs Rating
-
Industry
Pharmaceuticals

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

TerrAscend Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
TRSSF-36.76%-86.57%-33.07%-34%
S&P+14.5%+93.32%+14.09%+181%

TerrAscend Company Info

TerrAscend Corp. produces and sells medical cannabis products. The firm owns several businesses and brands, including The Apothecarium, Ilera Healthcare, Kind Tree, Prism, State Flower, Valhalla Confections and Arise Bioscience Inc. The company was founded by Basem Hanna, Vijay Sappani and Michael Nashat on March 7, 2017 and is headquartered in Mississauga, Canada.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$65.01M-16.1%
Gross Profit$31.95M-10.0%
Gross Margin49.15%3.4%
Market Cap$85.49M-78.3%
Market Cap / Employee$0.07M0.0%
Employees1.2K-0.2%
Net Income-$6.41M-2.7%
EBITDA$14.79M-14.0%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$26.78M-12.2%
Accounts Receivable$18.43M17.8%
Inventory35.4-30.6%

Liabilities

Q2 2025YOY Change
Long Term Debt$230.16M2.4%
Short Term Debt$12.04M-34.5%

Ratios

Q2 2025YOY Change
Return On Assets-12.38%-0.8%
Return On Invested Capital-31.44%35.7%

Cash Flow

Q2 2025YOY Change
Free Cash Flow$0.80M-93.0%
Operating Free Cash Flow$3.08M-76.2%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Book1.670.920.790.50-70.93%
Price to Sales1.170.610.470.29-75.97%
Price to Tangible Book Value-3.97-1.70-1.41-0.74-83.00%
Price to Free Cash Flow TTM11.536.705.986.51-37.38%
Enterprise Value to EBITDA72.2733.6725.1020.01-43.46%
Free Cash Flow Yield8.7%14.9%16.7%15.4%59.68%
Return on Equity-37.7%-38.3%-38.8%-44.5%44.24%
Total Debt$246.24M$246.18M$245.82M$242.20M-0.42%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.